Panbela Therapeutics Inc (PBLA) Earnings Report, Financial Results, Financial analysis

Panbela Therapeutics Inc increased IV. Quarter net loss per share of $-0.32 compare to net loss per share of $-0.26 recorded in the same quarter a year ago a decrease compare to $-0.21 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.32	$ 0 Mill
$-0.06	Unch.

Panbela Therapeutics Inc 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Panbela Therapeutics Inc is Expected to report next financial results on May 11, 2023.

More on PBLA's Income Statement

PBLA's NET INCOME

Panbela Therapeutics Inc 's in IV. Quarter recorded net loss of $-4.735 million, an increase from net loss of $-3.550 million in IV. Quarter a year ago.

Sequentially net loss advanced

More on PBLA's Growth

Panbela Therapeutics Inc Inventories
In IV. Quarter company's net cash and cash equivalents decreased by $-11 million

Earnings quality

Panbela Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Panbela Therapeutics Inc payed $ -1.04 cash per share, on a free-cash flow basis .

Tangible Book value fell to $ -0.55 per share from $ -0.40.

Company repurchased 6.13 million shares or 29.48 % in IV. Quarter.

• More on PBLA's Dividends

Market Capitalization (Millions)	6
Shares Outstanding (Millions)	15
Total Debt (Millions $)	7
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-35
Cash Flow (TTM) (Millions $)	-11
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Panbela Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Panbela Therapeutics Inc had negative $ -1.04 cash flow per share, on a free-cash flow basis .

Tangible Book value fell to $ -0.55 per share from $ -0.40.

Company repurchased 6.13 million shares or 29.48 % in IV. Quarter.

• More on PBLA's Balance Sheets

Market Capitalization (Millions)	6
Shares Outstanding (Millions)	15
Total Debt (Millions $)	7
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-35
Cash Flow (TTM) (Millions $)	-11
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar OCDX's Profile Stock Price OCDX's Financials Business Description Fundamentals Charts & Quotes OCDX's News Suppliers OCDX's Competitors Customers & Markets Economic Indicators OCDX's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Panbela Therapeutics Inc

PBLA's Financial Statements and Analysis